China SXT Pharmaceuticals (China SXT Pharmaceuticals) Additional Paid-In Capital : $35.95 Mil(As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Additional Paid-In Capital?

China SXT Pharmaceuticals's quarterly additional paid-in capital increased from Sep. 2022 ($32.56 Mil) to Mar. 2023 ($35.59 Mil) and increased from Mar. 2023 ($35.59 Mil) to Sep. 2023 ($35.95 Mil).

China SXT Pharmaceuticals's annual additional paid-in capital increased from Mar. 2021 ($25.32 Mil) to Mar. 2022 ($30.99 Mil) and increased from Mar. 2022 ($30.99 Mil) to Mar. 2023 ($35.59 Mil).

China SXT Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for China SXT Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Additional Paid-In Capital Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

7.95

17.16

25.32

30.99

35.59

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial									26.01	30.99	32.56	35.59	35.95

China SXT Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

China SXT Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.